Evaluation of Changes in Mental Health Parameters Following Ablation in Patients Treated with Pulmonary Vein Isolation

Öz

Aim: Atrial fibrillation (AF) is frequently associated with anxiety, depression, and impaired sleep quality. Pulmonary vein isolation (PVI) is an established ablation therapy for AF, yet its effects on mental health parameters remain less well explored. This study aimed to evaluate changes in anxiety, depression, and sleep quality before and after PVI. Material and Methods: In this cross-sectional study, 117 patients undergoing PVI for AF were evaluated using validated questionnaires before and after ablation. Mental health parameters included the Beck Anxiety Inventory (BAI), Beck Depression Inventory (BDI), and Pittsburgh Sleep Quality Index (PSQI). Pre- and post-procedure scores were compared to assess changes in psychological well-being. Percentage change (Δ) in scores was calculated as [(post–pre)/pre] × 100. Associations between Δ values and baseline demographic, clinical, laboratory, and echocardiographic parameters were examined. Results: The mean BAI score significantly decreased from 18.2 ± 5.1 at baseline to 15.0 ± 4.5 post-ablation, corresponding to a 20% reduction (p < 0.001). Similarly, a 19% decrease in BDI score was observed (p < 0.01). A 17% improvement in PSQI score was seen (p < 0.05). Greater improvements were noted in patients without coronary artery disease, while those with arrhythmia recurrence showed less benefit. In addition, patients with reduced baseline ejection fraction and enlarged ventricular dimensions experienced more pronounced psychological recovery. Conclusion: PVI not only restores sinus rhythm but also improves psychological well-being and sleep quality in AF patients. The magnitude of benefit is influenced by comorbidities, arrhythmia recurrence, and baseline cardiac function, with the most pronounced improvements observed in patients with impaired ventricular function and without CAD.

Anahtar Kelimeler

• atrial fibrillation
• pulmonary vein isolation
• ablation
• mental health
• anxiety
• depression
• sleep quality

Pulmoner Ven İzolasyonu ile Tedavi Edilen Hastalarda Ablasyon Sonrası Ruh Sağlığı Parametrelerindeki Değişikliklerin Değerlendirilmesi

Öz

Amaç: Atrial fibrilasyon (AF), sıklıkla anksiyete, depresyon ve uyku bozuklukları ile ilişkilidir. Pulmoner ven izolasyonu (PVI), AF tedavisinde standart ablasyon yöntemlerinden biridir; ancak mental sağlık parametreleri üzerindeki etkileri yeterince araştırılmamıştır. Bu çalışmada ablasyon öncesi ve sonrası anksiyete, depresyon ve uyku kalitesindeki değişiklikler incelendi. Yöntemler: Kesitsel tasarıma sahip bu çalışmada 117 AF nedeniyle PVI uygulanan hastalar, işlem öncesi ve sonrası validasyonlu ölçeklerle değerlendirildi. Mental sağlık parametreleri Beck Anksiyete Ölçeği (BAI), Beck Depresyon Ölçeği (BDI) ve Pittsburgh Uyku Kalitesi İndeksi (PSQI) ile ölçüldü. İşlem öncesi ve sonrası skorlar karşılaştırılarak psikolojik iyilik halindeki değişim belirlendi. Skorlardaki değişim yüzdesi Δ = [(sonra–önce)/önce] × 100 formülü ile hesaplandı. Δ değerleri ile demografik, klinik, laboratuvar ve ekokardiyografik parametreler arasındaki ilişkiler incelendi. Bulgular: Ortalama BAI skoru, başlangıçtaki 18,2 ± 5,1'den ablasyon sonrası 15,0 ± 4,5'e önemli ölçüde düştü; bu da %20'lik bir azalmaya karşılık geliyor (p < 0,001). Benzer şekilde, BDI skoru %19'luk bir azalma gözlendi (p < 0,01). PSQI skorunda %17'lik bir iyileşme görüldü (p < 0,05). Koroner arter hastalığı olmayan hastalarda daha fazla iyileşme kaydedilirken, aritmi tekrarı olan hastalarda daha az fayda görüldü. Ayrıca, bazal ejeksiyon fraksiyonu azalmış ve ventrikül boyutları büyümüş hastalarda psikolojik iyileşme daha belirgindi. Sonuç: PVI, AF hastalarında yalnızca ritim kontrolü sağlamaz, aynı zamanda ruh sağlığı ve uyku kalitesini de iyileştirir. İyileşme derecesi komorbiditeler, aritmi rekürrensi ve kardiyak fonksiyonla ilişkilidir; özellikle ventrikül fonksiyonu bozulmuş ve CAD olmayan hastalar en belirgin faydayı görmektedir.

Anahtar Kelimeler

• atriyal fibrilasyon
• pulmoner ven izolasyonu
• ablasyon
• mental sağlık
• anksiyete
• depresyon
• uyku kalitesi

Kaynakça

1. Patel D, Mc Conkey ND, Sohaney R, Mc Neil A, Jedrzejczyk A, and Armaganijan L. A systematic review of depression and anxiety in patients with atrial fibrillation: the mind-heart link. Cardiovasc Psychiatry Neurol. 2013;2013:159850. DOI: 10.1155/2013/159850.
2. Galli F, Borghi L, Carugo S, et al. Atrial fibrillation and psychological factors: a systematic review. PeerJ. 2017;5:e3537. DOI: 10.7717/peerj.3537.
3. Thrall G, Lip GY, Carroll D, and Lane D. Depression, anxiety, and quality of life in patients with atrial fibrillation. Chest. 2007;132(4):1259-64. DOI: 10.1378/chest.07-0036.
4. Gisi B, Althouse AD, Mathier AS, et al. The unmeasured burden: Contribution of depression and psychological stress to patient-reported outcomes in atrial fibrillation. Int J Cardiol. 2020;302:75-80. DOI: 10.1016/j.ijcard.2019.12.004.
5. Jain SK, Novak PG, Sangrigoli R, et al. Sustained quality-of-life improvement post-cryoballoon ablation in patients with paroxysmal atrial fibrillation: Results from the STOP-AF Post-Approval Study. Heart Rhythm. 2020;17(3):485-91. DOI: 10.1016/j.hrthm.2019.10.014.
6. Sang CH, Chen K, Pang XF, et al. Depression, anxiety, and quality of life after catheter ablation in patients with paroxysmal atrial fibrillation. Clin Cardiol. 2013;36(1):40-5. DOI: 10.1002/clc.22039.
7. Al-Kaisey AM, Parameswaran R, Bryant C, et al. Atrial Fibrillation Catheter Ablation vs Medical Therapy and Psychological Distress: A Randomized Clinical Trial. JAMA. 2023;330(10):925-33. DOI: 10.1001/jama.2023.14685.
8. Pavlicek V, Wedegartner SM, Millenaar D, et al. Heart-Focused Anxiety, General Anxiety, Depression and Health-Related Quality of Life in Patients with Atrial Fibrillation Undergoing Pulmonary Vein Isolation. J Clin Med. 2022;11(7) DOI: 10.3390/jcm11071751.

9. Sayin Kasar K and Ozer S. An Overlooked Detail: Sleep and Quality of Life in Patients with Atrial Fibrillation. P R Health Sci J. 2023;42(1):16-22.
10. Hu WS and Lin CL. CHA2DS2-VASc score for ischaemic stroke risk stratification in patients with chronic obstructive pulmonary disease with and without atrial fibrillation: a nationwide cohort study. Europace. 2018;20(4):575-81. DOI: 10.1093/europace/eux065.
11. Zhu W, He W, Guo L, Wang X, and Hong K. The HAS-BLED Score for Predicting Major Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: A Systematic Review and Meta-analysis. Clin Cardiol. 2015;38(9):555-61. DOI: 10.1002/clc.22435.
12. Ji L, Zhang Q, Wang R, Zhang D, and Xu C. Association of C(2)HEST Score and New-Onset Atrial Fibrillation in Patients with Non-ST-Segment Elevation Myocardial Infarction. Med Sci Monit. 2025;31:e949555. DOI: 10.12659/MSM.949555.
13. Argon H, Banu K, Zeliha Ü, Süleyman D, and Turan A. Phenolic Content and In-vitro Antioxidant Activity of Olea europaea L. subs. oleaster Leaves by Supercritical CO 2 Extraction. Ereğli Tarım Bilim. Derg. 2023;3:75-85.
14. Beck AT, Ward CH, Mendelson M, Mock J, and Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-71. DOI: 10.1001/archpsyc.1961.01710120031004.
15. Carpi M. The Pittsburgh Sleep Quality Index: a brief review. Occup Med (Lond). 2025;75(1):14-15. DOI: 10.1093/occmed/kqae121.
16. Wood KA, Higgins MK, and Barnes AH. Self-reported Sleep Quality Before and After Atrial Fibrillation Ablation. J Cardiovasc Nurs. 2023;38(2):E78-E86. DOI: 10.1097/JCN.0000000000000909.
17. Risom SS, Fevejle Cromhout P, Overgaard D, Hastrup Svendsen J, and Kikkenborg Berg S. Effect of Rehabilitation on Sleep Quality After Ablation for Atrial Fibrillation: Data From a Randomized Trial. J Cardiovasc Nurs. 2018;33(3):261-68. DOI: 10.1097/JCN.0000000000000476.
18. Cang J, Shi N, Zhu D, Liu Y, Zhou Q, and Chen L. Self-reported sleep pattern and recurrence of atrial fibrillation after catheter ablation. Clin Cardiol. 2023;46(3):336-44. DOI: 10.1002/clc.23975.
19. Dorian P and Angaran P. Symptoms and Quality of Life After Atrial Fibrillation Ablation: Two Different Concepts. JACC Clin Electrophysiol. 2017;3(10):1177-79. DOI: 10.1016/j.jacep.2017.06.007.
20. Askin L, Uzel KE, Tanrıverdi O, Kavalcı V, Yavcin O, and Turkmen S. The relationship between coronary artery disease and depression and anxiety scores. Northern clinics of Istanbul. 2020;7(5):523-23.
21. Carney RM and Freedland KE. Depression and coronary heart disease. Nat Rev Cardiol. 2017;14(3):145-55. DOI: 10.1038/nrcardio.2016.181.
22. Raine D, Langley P, Shepherd E, et al. Effect of catheter ablation on quality of life in patients with atrial fibrillation and its correlation with arrhythmia outcome. Open Heart. 2015;2(1):e000302. DOI: 10.1136/openhrt-2015-000302.
23. Wedegartner SM, Schwantke I, Kindermann I, and Karbach J. Predictors of heart-focused anxiety in patients with stable heart failure. J Affect Disord. 2020;276:380-87. DOI: 10.1016/j.jad.2020.06.065.
24. Mulder MJ, Kemme MJB, van Pouderoijen N, et al. Determinants of symptom relief and quality of life improvement after atrial fibrillation ablation. Eur Heart J Qual Care Clin Outcomes. 2025; DOI: 10.1093/ehjqcco/qcaf045.
25. Bilgen KB and Ozlem K. Recovery of mental health parameters after ablation in patients with premature ventricular complex induced cardiomyopathy. Eur Rev Med Pharmacol Sci. 2022;26(10):3703-11. DOI: 10.26355/eurrev_202205_28866.
26. Hasebe H and Shinba T. Decreased anxiety after catheter ablation for paroxysmal atrial fibrillation is associated with augmented parasympathetic reactivity to stress. Heart Rhythm O2. 2020;1(3):189-99. DOI: 10.1016/j.hroo.2020.05.008.